Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Lysosomal phospholipase A2 (LPLA2) activity as a therapeutic target for treating systemic lupus erythematosus

Lysosomal phospholipase A2 (LPLA2) activity as a therapeutic target for treating systemic lupus erythematosus

US Patent 9309553 · Granted Apr 12, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods for processing carbonaceous feedstock2024
Systems and methods for processing carbonaceous feedstock2022
Sample plate holder2022
Glucosylceramide synthase inhibitors and therapeutic methods using the same2022
Charged particle beam system and method of measuring sample using scanning elect2022
Systems and methods for processing carbonaceous feedstock2021
Scanning electron microscope and image processing method2021
Liquid ejecting apparatus2020
Liquid ejecting apparatus and drive circuit2020
Electron microscope and control method2020
Radar antenna unit and radar device2019
Liquid ejecting apparatus and capacitive load drive circuit2019